A case of relapsing aseptic meningitis under excellent tumor response to pembrolizumab in microsatellite instability-high recurrent endometrial cancer

• This is the first report of aseptic meningitis due to immune checkpoint inhibitor treatment in endometrial cancer. • The meningitis was severe and relapsed multiple times unlike in other reported cases. • Oncologic outcome was excellent after overcoming this severe adverse event.

Detalles Bibliográficos
Autores principales: Noguchi, Daito, Seki, Toshiyuki, Kubonoya, Yutaro, Komazaki, Hiromi, Ozone, Hirokazu, Yanaihara, Nozomu, Takano, Hirokuni, Okamoto, Aikou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Reports and Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651784/
https://www.ncbi.nlm.nih.gov/pubmed/34926766
http://dx.doi.org/10.1016/j.gore.2021.100885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651784/
https://www.ncbi.nlm.nih.gov/pubmed/34926766
http://dx.doi.org/10.1016/j.gore.2021.100885

Ejemplares similares